Alpha 2.0
Login Register
» Articles » PMID: 33257892

Toward Superhuman SARS-CoV-2 Immunity?

Overview
Journal Nat Med
Specialties General Medicine
Molecular Biology
Date 2020 Dec 1
PMID 33257892
Citations 10
Authors
Dennis R Burton
Eric J Topol
Affiliations
Soon will be listed here.
Citing Articles

Prospects of animal models and their application in studies on adaptive immunity to SARS-CoV-2.

Wei X, Rong N, Liu J Front Immunol. 2022; 13:993754.

PMID: 36189203 PMC: 9523127. DOI: 10.3389/fimmu.2022.993754.

COVID-19 and plasma cells: Is there long-lived protection?.

Nguyen D, Lamothe P, Woodruff M, Saini A, Faliti C, Sanz I Immunol Rev. 2022; 309(1):40-63.

PMID: 35801537 PMC: 9350162. DOI: 10.1111/imr.13115.

Pulmonary Inflammatory Response in Lethal COVID-19 Reveals Potential Therapeutic Targets and Drugs in Phases III/IV Clinical Trials.

Lopez-Cortes A, Guerrero S, Ortiz-Prado E, Yumiceba V, Vera-Guapi A, Leon Caceres A Front Pharmacol. 2022; 13:833174.

PMID: 35422702 PMC: 9002106. DOI: 10.3389/fphar.2022.833174.

Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges.

Kandimalla R, Chakraborty P, Vallamkondu J, Chaudhary A, Samanta S, Reddy P Biomedicines. 2021; 9(11).

PMID: 34829969 PMC: 8615473. DOI: 10.3390/biomedicines9111740.

Discovery and characterization of high-affinity, potent SARS-CoV-2 neutralizing antibodies via single B cell screening.

Schardt J, Pornnoppadol G, Desai A, Park K, Zupancic J, Makowski E Sci Rep. 2021; 11(1):20738.

PMID: 34671080 PMC: 8528929. DOI: 10.1038/s41598-021-99401-x.

References
1.
Amanna I, Slifka M . Successful Vaccines. Curr Top Microbiol Immunol. 2018; 428:1-30. PMC: 6777997. DOI: 10.1007/82_2018_102. View